Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   540,054    

Indirect Shares

   247,533      
Direct Value   $43,092,104    

Indirect Value

   $21,938,850      
Total Shares   787,587      
Total Value   $65,030,954      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
            Keros Therapeutics, Inc. KROS 2024-06-01 200 0    Premium*  
* Premium Members only  

Records found :    853         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 26 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-12-27 4 AS $86.16 $430,800 D/D (5,000) 327,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-03-22 4 D $78.52 $433,352 D/D (5,519) 302,498 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-21 4 AS $48.57 $437,137 D/D (9,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-06-01 4 AS $87.53 $437,650 D/D (5,000) 233,564 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-01-13 4 AS $87.86 $439,300 D/D (5,000) 303,789 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-05-04 4 AS $88.00 $440,000 D/D (5,000) 298,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-05-24 4 AS $88.38 $441,900 D/D (5,000) 233,564 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-05-06 4 D $80.80 $442,703 D/D (5,479) 390,156 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-11 4 AS $88.96 $444,780 D/D (5,000) 328,701 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-01-12 4 AS $89.00 $445,000 D/D (5,000) 303,789 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-05-12 4 AS $89.23 $446,150 D/D (5,000) 238,496 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-06-02 4 AS $89.70 $448,500 D/D (5,000) 233,564 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-16 4 D $80.72 $448,803 D/D (5,560) 334,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-05-15 4 D $91.50 $451,278 D/D (4,932) 233,564 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-06-05 4 AS $90.56 $452,800 D/D (5,000) 226,924 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-10 4 AS $91.09 $455,450 D/D (5,000) 206,364 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-15 4 AS $91.42 $457,100 D/D (5,000) 206,364 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-05-17 4 AS $91.73 $458,650 D/D (5,000) 233,564 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-16 4 AS $91.96 $459,800 D/D (5,000) 190,674 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-13 4 AS $92.68 $463,400 D/D (5,000) 206,364 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-01 4 D $94.76 $465,177 D/D (4,909) 328,701 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-05-08 4 AS $93.17 $465,850 D/D (5,000) 238,496 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-04-25 4 AS $94.00 $470,000 D/D (5,000) 238,194 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-05-02 4 OE $12.99 $474,135 D/D 36,500 432,135 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-04-27 4 AS $95.72 $478,600 D/D (5,000) 238,194 0 -
  853  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26  27   28   29   30   31   32   33   34   35      
  Page 26 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us